Radar · Life Sciences in Berlin
Best Life Sciences Companies in Berlin, Germany
The 238 best Life Sciences companies in Berlin, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: T-Knife.
By Rohit KhannaTrends & Stories
238companies tracked
$1.1Bdisclosed funding
0unicorns
96have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × BERLIN
Our analysis of 50 Life Sciences companies
$3.3b in tracked funding; 51% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2024.
50companies analysed
51%cloud-native stacks
2024funding peak (by rounds)
2016median founding year
40median Fliar Index™
200kcombined LinkedIn audience
46%of audience held by top 3
1companies hiring publicly (12 mo)
Ranked: Best Life Sciences companies in Berlin
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | T-Knife Developer of tumor-specific T cell receptor therapies for the treatment of cancer | $188M | 58 mo ago | 8 | Elisa Kieback Co-Founder & CEO | VimeoApache HTTP ServerCloudflare+10 | Top 50M | 20 patents Engineered T‑cell immunotherapy constructs: chimeric CD8/CD95 receptors and KRAS‑specific TCRs | 1 expansion |
| 2 | Glycotope Developer of Glyco-optimized antibodies and provider of contract research and manufacturing services. | $166M | 128 mo ago | 116 | Steffen Goletz CEO | — | — | 495 patents Recombinant surfactant protein D production and anti‑MUC1 antibody therapeutics | — |
| 3 | Noxxon Pharma Developer of aptamers to target the tumour microenvironment | $93M | 53 mo ago | 13 | — | — | — | 362 patents Nucleic‑acid chemokine modulators and polyalkoxylation methods for cancer therapeutics | — |
| 4 | ResearchGate Online community for scientists | $88M | 66 mo ago | 150 150 → 351 (+134%) | Horst Fickenscher CIO & Co-Founder | GitBookZendeskApple iCloud Mail+14 | Top 500k | — | 1 partnership |
| 5 | Aignostics Developer of artificial intelligence software for biomedical image analysis applications 64AI top 25%Growth top 26%Funding top 27%Talent top 28% All 11 signals ▾AItop 25% Growthtop 26% Fundingtop 27% Talenttop 28% Moattop 39% Innovationtop 47% Patentstop 47% Techbottom 49% Globalbottom 37% Marketbottom 35% Newsbottom 18% AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) Growth: Headcount 10 → 25 (+150%) across vintages · Web rank 5,000,000 → 10,000,000 YoY rank vs industry peers · Fliar Intelligence Index 64/100 | $55M | 19 mo ago | 25 | Maximilian Alber Co-Founder & CTO | WebflowApple iCloud MailGoogle Workspace+18 | Top 5M | 5 patents AI-driven detection and classification of biological structures for medical imaging diagnostics | 1 partnership · 1 award |
| 6 | Epigenomics Molecular Diagnostics for Cancer | $53M | 65 mo ago | 32 | Greg Hamilton CEO | WordPressMySQLPHP+12 | Top 50M | 793 patents DNA methylation‑based liquid biopsy biomarkers for early cancer detection and prognosis | — |
| 7 | Ariceum Therapeutics Developer of drugs for systemic targeted radiation therapy to treat cancer | $52M | 38 mo ago | 26 | Manfred Ruediger CEO | — | — | 21 patents Alpha‑emitting somatostatin‑receptor radiopharmaceuticals for targeted cancer therapy. | — |
| 8 | FORMEL Skin Manufacturer of dermatological skin care products | $40M | 53 mo ago | 71 | Florian Semler Co-Founder | Cart FunctionalityShopifyBootstrap+28 | Top 500k | — | — |
| 9 | OMEICOS Developer of synthetic omega 3 analogues for treating cardiovascular diseases | $35M | 91 mo ago | 15 15 → 9 (-40%) | Dominik Muller Co-Founder | — | — | — | — |
| 10 | Tacalyx Developer of therapeutic agents for cancer treatment 16News top 32%Growth top 35%Funding top 37%Moat top 47% All 9 signals ▾Newstop 32% Growthtop 35% Fundingtop 37% Moattop 47% Patentsbottom 38% Globalbottom 37% Marketbottom 25% Techbottom 23% Innovationbottom 21% News: 4 BI events in 12 mo (of 6 tracked, 2 types) · Top themes: Leadership, Funding Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 16/100 | $23M | 1 mo ago | 9 | — | PHPCKEditorGoogle Maps+11 | Top 50M | 2 patents Glycoengineered therapeutic antibodies targeting Globo H cancer antigens | — |
| 11 | DiaMonTech Developer of non-invasive blood glucose monitoring technology 53Talent top 23%Moat top 25%Innovation top 31%Patents top 34% All 10 signals ▾Talenttop 23% Moattop 25% Innovationtop 31% Patentstop 34% Fundingtop 35% Growthtop 45% Globalbottom 42% Techbottom 38% Marketbottom 34% Newsbottom 22% Talent: 5 named leaders on record · 5 C-suite/founder profiles curated Moat: Editorial + unicorn rating 7/10 · IP moat: 92 patents rank vs industry peers · Fliar Intelligence Index 53/100 | $19M | 19 mo ago | 29 | Werner Mäntele Co-Founder & Head Of Research And Development | WebflowYouTubecore-js+10 | Top 5M | 92 patents Optical spectroscopy devices for in‑tissue analyte detection and concentration monitoring | 1 internship |
| 12 | Inne Provider of an at-home fertility monitoring system for women | $19M | 48 mo ago | 14 | — | Cart FunctionalityShopifySentry+35 | Top 5M | — | 1 partnership |
| 13 | Dopavision Developer of a digital therapeutic for myopia | $17M | 59 mo ago | 17 | — | — | — | 21 patents Non‑invasive photostimulation devices for targeted optic nerve/retinal therapy | — |
| 14 | BEBIG Medical Provider of radiation therapy products for cancer treatment and care | $16M | 29 mo ago | — | Julian Schroder Co-CEO | Animate.cssNginxModernizr+3 | Top 10M | — | — |
| 15 | StratifAI Developer of multimodal artificial intelligence models to improve cancer diagnosis and treatment 55Talent top 28%AI top 30%Funding top 32%Tech top 42% All 7 signals ▾Talenttop 28% AItop 30% Fundingtop 32% Techtop 42% Growthtop 45% Globalbottom 39% Marketbottom 29% Talent: 4 named leaders on record · 4 C-suite/founder profiles curated AI: Classified as an AI company · Product described with: artificial intelligence rank vs industry peers · Fliar Intelligence Index 55/100 | $16M | 8 mo ago | — | Firas Khader CTO & Co-founder | WordPressApple iCloud MailMicrosoft 365+25 | Top 10M | — | — |
| 16 | Caprotec Technology platform for proteomics research in biopharma | $15M | 181 mo ago | 11 | — | — | — | — | — |
| 17 | Eternygen Small molecule for the treatment of metabolic diseases | $14M | 67 mo ago | 1 | — | — | — | 4 patents Citrate transporter inhibition therapeutics for metabolic/oncology applications | — |
| 18 | Myelo Therapeutics Small molecules to treat chemotherapy-induced myelosuppression | $13M | 42 mo ago | 10 | — | — | — | 8 patents Imidazole-based radioprotective compounds for treating lethal radiation exposure symptoms | — |
| 19 | Molecule Platform where drug development researchers and investors collaborate to invent therapeutics | $13M | 47 mo ago | 31 | Paul Kohlhaas Co-Founder & CEO | SanityTurbopackstyled-components+17 | Top 50M | — | 1 launch |
| 20 | Apheris Provider of data analytics solutions for life science industry 53AI top 20%Growth top 35%Talent top 38%Funding top 39% All 10 signals ▾AItop 20% Growthtop 35% Talenttop 38% Fundingtop 39% Partnerstop 41% Techbottom 43% Globalbottom 39% Moatbottom 38% Marketbottom 30% Newsbottom 18% AI: Classified as an AI company Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 53/100 | $12M | 17 mo ago | 19 | Robin Rohm Co-Founder & CEO & MD | DatoCMSNode.jsUnoCSS+10 | Top 10M | — | — |
| 21 | her1 Manufacturer of dietary supplements for multiple ailments | $11M | 58 mo ago | 28 | Chanyu Xu Founder | ShopifyYouTubeAmazon Web Services+35 | Top 1M | — | — |
| 22 | Labforward Laboratory data, devices, and researchers collaboration platform | $10M | 61 mo ago | 45 | — | HubSpot CMS HubReactEmotion+27 | Top 10M | — | — |
| 23 | Audiocure Drug development for hearing disorders with a high unmet medical need 16Growth top 45%Funding top 47%Talent bottom 49%Global bottom 37% All 6 signals ▾Growthtop 45% Fundingtop 47% Talentbottom 49% Globalbottom 37% Techbottom 22% Marketbottom 20% Growth: Web rank 5,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo Funding: Raised $9.6M across 1 rounds · 1 rounds over 14 yrs (0.1/yr) rank vs industry peers · Fliar Intelligence Index 16/100 | $10M | 16 mo ago | 7 | Reimar Schlingensiepen CEO | WordPressMySQLPHP+13 | Top 5M | — | — |
| 24 | Humedics Point-of-care breath-based assay for assessment of liver function | $9M | 139 mo ago | 11 11 → 9 (-18%) | — | — | — | 69 patents Laser frequency control devices and infrared spectroscopy-based metabolic enzyme assay instrumentation | — |
| 25 | Cellbricks Therapeutics Developer of implantable tissue therapeutics using biofabrication 50Growth top 28%Talent top 28%Global top 42%Funding bottom 49% All 6 signals ▾Growthtop 28% Talenttop 28% Globaltop 42% Fundingbottom 49% Techbottom 49% Marketbottom 31% Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo Talent: 4 named leaders on record · 4 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 50/100 | $8M | 2 mo ago | — | Alexander Thomas Co-Founder | WordPressMySQLPHP+19 | Top 10M | — | 1 partnership · 1 award |
| 26 | OctreoPharm Sciences Theranostic compounds for neuroendocrine tumours. | $7M | 182 mo ago | 11 | — | — | — | — | — |
| 27 | Alacris Theranostics Genomics service provider | $7M | 89 mo ago | 20 20 → 13 (-35%) | Hans Lehrach Founder | WordPress Block EditorWordPressMySQL+16 | Top 50M | 41 patents Molecular diagnostics and biomarker discovery using nanotech optical detection and therapy efficacy assays | — |
| 28 | Mologen Vaccines and immunomodulators for the treatment of cancer and infectious diseases | $6M | 99 mo ago | 38 | — | — | — | 263 patents Synthetic immunostimulatory oligonucleotide therapeutics for HIV, cancer immunotherapy, and vaccine adjuvants | — |
| 29 | Jenlab Developer of multiphoton tomography and fluorescence lifetime imaging microscopy technology | $6M | 59 mo ago | — | Karsten Koenig CEO | — | — | 36 patents Multimodal optical imaging, laser dental hard‑tissue machining, and flow‑based tumor cell detection | — |
| 30 | Baze Personalized vitamin supplements based on biochemical tests | $6M | 82 mo ago | 34 | — | — | — | — | — |
| 31 | Scienion Solutions for the genomics and proteomics industry | $6M | 74 mo ago | 114 114 → 111 (-3%) | — | WordPressApple iCloud MailMySQL+15 | Top 50M | 86 patents Microfluidic droplet dispensing and precision sample preparation for analytical instrumentation | 1 launch |
| 32 | Nostos Genomics Developer of AI platform for interpretation of genetic variants and mutations | $6M | 52 mo ago | 20 | — | — | Top 50M | 3 patents Computational tools for classifying and prioritizing genetic variants in genomics | — |
| 33 | GetSteps Manufacturer of custom-made orthopedic insoles designed to support feet and body | $5M | 59 mo ago | 19 | Annik Wolf Co-Founder | Cart FunctionalityShopifySentry+42 | Top 5M | — | — |
| 34 | Nuuron Developer of a digital drug to treat Alzheimer's disease | $4M | 19 mo ago | — | Fabian Queisner Co-Founder & CEO | — | — | 5 patents Non‑invasive high‑frequency brain stimulation devices for neural oscillation modulation | — |
| 35 | TME Pharma Developer of novel therapies to treat cancer | $3M | 47 mo ago | 13 | — | JoomlaPHPBootstrap+7 | Top 10M | — | — |
| 36 | Healthmetrix Digital solutions to aggregate and analyze data from multiple sources for research purposes | $2M | 89 mo ago | — | Gabriel Sieglerschmidt Founder & CEO | — | — | — | — |
| 37 | TissUse Developer of a multi-organ chip platform for tissue culture | $2M | 60 mo ago | 31 31 → 38 (+23%) | Reyk Horland CEO | ContaoPHPApache HTTP Server+3 | Top 10M | 83 patents Microfluidic multi‑organ‑on‑a‑chip platforms for iPSC‑derived tissue modeling | — |
| 38 | MOBY Provider of autonomous logistics solutions for sensitive environments | $2M | 43 mo ago | — | Janis Munch Founder & CEO | — | — | — | — |
| 39 | Exazyme Developer of an AI protein design tool for biotech innovators | $2M | 37 mo ago | 5 | Jelena Ivanovska Co-Founder | — | — | — | — |
| 40 | Combinature Biopharm Microorganism genome libraries to develop pharmacologically active natural substances | $2M | 241 mo ago | — | David James Michael Dally CEO | — | — | 22 patents Lysolipid and lipopeptide antimicrobial agents, plus PDZ-domain therapeutic modulators. | — |
| 41 | Belyntic Provides technology for purification and modification of chemically synthesized peptides | $1M | 81 mo ago | 3 | Oliver Reimann Co-Founder | — | — | 20 patents Traceless cleavable linkers for solid‑phase peptide synthesis and purification | — |
| 42 | Lucid Genomics Developer of AI-based platform to analyse genomic mutation detection and prioritization | $1M | 21 mo ago | — | Uira Melo Co-Founder & CEO | Cart FunctionalitySquarespace CommerceSquarespace+14 | Top 10M | — | 1 launch · 3 partnerships |
| 43 | MyoPax Developer of regenerative therapies to treat muscle disorders | $1M | 36 mo ago | 2 | Verena Wolf CEO | WordPressMySQLPHP+9 | Top 50M | — | 1 award |
| 44 | Yendou Provider of a site engagement platform for clinical trials | $1M | 27 mo ago | — | Zina Sarif Founder & CEO | GSAPLiteSpeedCloudflare+11 | Top 50M | — | 1 partnership |
| 45 | Yendou Provider of data management and CRM platform for clinical operations | $1M | 27 mo ago | 3 | Patrick Rogg Co-Founder | — | — | — | — |
| 46 | Ospin Develops platforms for biotechnology applications | $974K | 63 mo ago | 29 | Jan Saam Co-Founder & CEO | — | — | 7 patents Bioreactor platforms for cardiac tissue engineering and mechanobiology applications | — |
| 47 | DeepSpin Provider of an AI-based MRI imaging solution | $675K | 71 mo ago | 17 | Clemens Tepel Co-Founder & CEO & MD | WixSentryBootstrap+10 | Top 50M | 11 patents MRI system hardware: rotatable magnetic fields, coil geometry, and thermal management. | — |
| 48 | ImmunoLogik Developer of novel antiviral drug candidates targeting host cell structures | $630K | 58 mo ago | 2 | Ulrich Schubert Co-Founder | — | — | 26 patents Antiviral therapeutics targeting coronavirus/retrovirus via small-molecule and lectin inhibitors | — |
| 49 | BioNeex Provider of SaaS-based drug licensing and drug candidate partnership exchange platform for the biopharma… | $500K | 28 mo ago | 13 | Smbat Rafayelyan Founder & CEO | — | — | — | 1 launch · 1 partnership |
| 50 | Nocturne Provider of medical image analysis platform | $271K | 48 mo ago | 3 | Ella Kadas Managing Director | — | — | 4 patents Retinal optical coherence tomography (OCT) image quality assessment and control | — |
Top 12 Life Sciences companies in Berlin
#1
Seed · Berlin, Berlin · founded 2018 · 9 employees$22.8Mraised▾
Seed · Berlin, Berlin · founded 2018 · 9 employees
Tacalyx is developing therapeutic agents for cancer treatment. The lead products are developed to target cancer-specific carbohydrate antigens that are located on the surface of metastatic malignant tumors (TACAs and other related cell surface glycans).
Fliar Intelligence Index™ 16how this company ranks against its industry peers
News
top 32%Growth
top 35%Funding
top 37%Moat
top 47%Patents
bottom 38%Global
bottom 37%News: 4 BI events in 12 mo (of 6 tracked, 2 types) · Top themes: Leadership, Funding
Growth: Fresh capital in last 24 mo
Funding: Raised $22.8M across 3 rounds · 3 rounds over 7 yrs (0.4/yr) · Last round Seed (Apr 2026)
Audience (LinkedIn): 3k LinkedIn followers
Activity (LinkedIn): 1 partnerships (incl. Biotechnology Innovation Organization (BIO)) announced in 12 mo
Funding rounds
- Apr 2026Seed$12.9M
- Jun 2024Seed$15.1M
- Sep 2019Seed$7.7M
Investors
Boehringer Ingelheim Venture Fund, Kurma Partners, Creathor Venture, Coparion, Idinvest Partners, HTGF
Tech stack
Closure LibraryGoogle Font ApiIonosLit-ElementLit-HtmlMicrosoft 365
#2
Seed · Berlin, Berlin · founded 2016$8.1Mraised▾
Seed · Berlin, Berlin · founded 2016
Developer of implantable tissue therapeutics using biofabrication. This company develops and produces implantable tissue therapeutics to address the limitations of current injectable cell therapies. The approach involves combining therapeutic cells with biomaterials through a proprietary light-based bioprinting platform. The resulting implantable tissues are designed to be biologically functional, immune-compatible, and optimized for surgical implantation, leading to sustainable therapeutic effects. The technology enables the creation of vascularized, complex tissue at scale.
Fliar Intelligence Index™ 50how this company ranks against its industry peers
Growth
top 28%Talent
top 28%Global
top 42%Funding
bottom 49%Tech
bottom 49%Market
bottom 31%Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo
Talent: 4 named leaders on record · 4 C-suite/founder profiles curated
Global: Legal entities in 2 countries: Germany, United States · Investors from 3 countries beyond Germany
Audience (LinkedIn): 8k LinkedIn followers — 3.9% of this cohort's audience
Activity (LinkedIn): 1 partnerships · 1 awards · 1 expansions (incl. ExpoR&D | Catalzye360) announced in 12 mo
Funding rounds
- Mar 2026Seed$8.1M
Founders & team
Investors
Silicon Roundabout Ventures, SPRIND, ACT, Brooks Hill Partners
Tech stack
AstraComplianzCore-JsElementorElementor Header & Footer BuilderGoogle Analytics
#3
Series A · Berlin, Berlin · founded 2023$16.3Mraised▾
Series A · Berlin, Berlin · founded 2023
Developer of multimodal artificial intelligence models to improve cancer diagnosis and treatment. The company's proprietary algorithms analyze the image, assessing various patterns that indicate the recurrence risk of breast cancer to provide a comprehensive prognostic evaluation.
Fliar Intelligence Index™ 55how this company ranks against its industry peers
Talent
top 28%AI
top 30%Funding
top 32%Tech
top 42%Growth
top 45%Global
bottom 39%Talent: 4 named leaders on record · 4 C-suite/founder profiles curated
AI: Classified as an AI company · Product described with: artificial intelligence
Funding: Raised $16.3M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) · Last round Series A (Sep 2025)
Audience (LinkedIn): 2k LinkedIn followers
Activity (LinkedIn): 2 partnerships · 2 awards (incl. German Medical Institute Cyprus (GMI)) announced in 12 mo
Funding rounds
- Sep 2025Series A$14.7M
- Sep 2024Seed$1.7M
Founders & team
Investors
Neulogy Ventures, MultiplexDX, Debiopharm, Arve Capital, Picus Capital, Alven
Tech stack
Apple Icloud MailCloudflareFlickityGoogle AnalyticsGoogle Tag ManagerGsap
#4
Series B · Berlin, Berlin · founded 2018 · 25 employees$55Mraised▾
Series B · Berlin, Berlin · founded 2018 · 25 employees
Developer of artificial intelligence software for biomedical image analysis applications. This technology processes pathology samples to identify drug targets and biomarkers. The software utilizes foundation models to generate embeddings for downstream analysis of tumor microenvironments. These tools support research in drug development and clinical diagnostics by predicting expression patterns and classifying cell types within tissue images.
Fliar Intelligence Index™ 64how this company ranks against its industry peers
AI
top 25%Growth
top 26%Funding
top 27%Talent
top 28%Moat
top 39%Innovation
top 47%AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) · Product described with: artificial intelligence
Growth: Headcount 10 → 25 (+150%) across vintages · Web rank 5,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo
Funding: Raised $55.0M across 3 rounds · 3 rounds over 6 yrs (0.5/yr) · Last round Series B (Oct 2024)
Audience (LinkedIn): 11k LinkedIn followers — 5.7% of this cohort's audience
Activity (LinkedIn): 1 partnerships · 1 awards (incl. Pancreatic Cancer Action Network) announced in 12 mo
Funding rounds
- Oct 2024Series B$34M
- Sep 2022Series A$14M
- Aug 2020Seed$5.9M
Founders & team
Investors
Boehringer Ingelheim Venture Fund, HTGF, Future Capital AG Hessen Life Sciences Chemie, IBB Ventures, Wellington Partners Venture Capital, CARMA FUND
Tech stack
Apple Icloud MailCloudflareCloudflare TurnstileGoogle AnalyticsGoogle Tag ManagerGoogle Workspace
#5
Series A · Berlin, Berlin · founded 2015 · 29 employees$19.2Mraised▾
Series A · Berlin, Berlin · founded 2015 · 29 employees
Developer of non-invasive blood glucose monitoring technology. This technology utilizes a novel laser-based method to measure glucose levels in interstitial fluid, eliminating the need for needles or test strips. The company is developing a handheld device for consumer use and a miniaturized sensor for integration into other devices. The technology is currently undergoing clinical trials and regulatory processes before market launch. A companion app is also under development to track glucose levels, along with other health data.
Fliar Intelligence Index™ 53how this company ranks against its industry peers
Talent
top 23%Moat
top 25%Innovation
top 31%Patents
top 34%Funding
top 35%Growth
top 45%Talent: 5 named leaders on record · 5 C-suite/founder profiles curated
Moat: Editorial + unicorn rating 7/10 · IP moat: 92 patents
Innovation: 92 patents (top 12% of patent-holders) · 35 filings since 2022 vs 56 in 2017-21 · Deep-tech classification: Tech Hardware
Audience (LinkedIn): 4k LinkedIn followers — 2.1% of this cohort's audience
Funding rounds
- Nov 2024Series A—
- Dec 2023Series A—
- Feb 2022Series A$5.7M
- Sep 2019Series A$7.7M
Founders & team
Investors
Disrupt Technology Venture, Unorthodox Ventures, Samsung Venture Investment, IBB Ventures, Golden Light, Yuanbio Venture Capital
Tech stack
BabelCloudflareCore-JsFinanceadsGoogle WorkspaceHsts
#6
Series A · Berlin, Berlin · founded 2019 · 19 employees$12.2Mraised▾
Series A · Berlin, Berlin · founded 2019 · 19 employees
Provider of data analytics solutions for life science industry. The platform enables organizations to collaborate on distributed data in real time. It offers a federated computational governance solution to support data-driven analysis. The platform allows users to build federated data networks to enable hospitals, fellow researchers and other pharmaceutical innovators to build predictive models.
Fliar Intelligence Index™ 53how this company ranks against its industry peers
AI
top 20%Growth
top 35%Talent
top 38%Funding
top 39%Partners
top 41%Tech
bottom 43%AI: Classified as an AI company
Growth: Fresh capital in last 24 mo
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Audience (LinkedIn): 10k LinkedIn followers — 4.8% of this cohort's audience
Funding rounds
- Jan 2025Series A$20.8M
- Nov 2022Seed$8.7M
- Aug 2020Seed$3M
- Grant (prize money)—
Founders & team
Investors
LocalGlobe, Another, system, Dig Ventures, Bmbf, Octopus Ventures
Tech stack
DatocmsHstsHubspotMicrosoft 365Node.JsNuxt.Js
#7
Series B · Berlin, Berlin · founded 2012 · 7 employees$9.6Mraised▾
Series B · Berlin, Berlin · founded 2012 · 7 employees
AudioCure Pharma develops neuropharmaceutical therapies for the treatment of hearing disorders. At present, the company is focusing on preclinical research and clinical development of novel pharmacotherapies to treat inner ear disorders (cochlear implant performance improvement & ototoxicity ) and vestibular system disorders (e.g. dizziness and vertigo). Its lead candidate, AC-102 is currently in late-stage preclinical development for the treatment of acute noise-induced hearing loss having demonstrated preclinical POC in 2016. AC102 acts as an antagonist of the multitude of pathological processes leading to hearing loss.
Fliar Intelligence Index™ 16how this company ranks against its industry peers
Growth
top 45%Funding
top 47%Talent
bottom 49%Global
bottom 37%Tech
bottom 22%Market
bottom 20%Growth: Web rank 5,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo
Funding: Raised $9.6M across 1 rounds · 1 rounds over 14 yrs (0.1/yr) · Last round Series B (Feb 2025)
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Audience (LinkedIn): 1k LinkedIn followers
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
- Feb 2025Series B—
- Nov 2016Series A$9.6M
- May 2012Seed—
Founders & team
Investors
HTGF, MED-EL, InfectoPharm
Tech stack
Apache Http ServerCookie NoticeDiviIp2Location.IoJqueryJquery Migrate
#8
Seed · Berlin, Berlin · founded 2023$3.8Mraised▾
Seed · Berlin, Berlin · founded 2023
Developer of a digital drug to treat Alzheimer's disease. It offers Memory-Pacemaker a non-invasive, photonic neurostimulation to re-enable patients with Alzheimer's Disease to store and recall memories again.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers
Funding rounds
- Oct 2024Seed$3.8M
Founders & team
Investors
HTGF, IBB Ventures, Caesar, Business Angels
#9
Series B · Berlin, Berlin · founded 2018 · 8 employees$188.2Mraised▾
Series B · Berlin, Berlin · founded 2018 · 8 employees
Tknife is a developer of tumor-specific T cell receptor therapies for the treatment of cancer. It is developing human TCRs to manufacture patient-derived T cell products targeting tumor-specific antigens for the treatment of various cancer. Its products help to detect cancer cells and initiate their elimination. The company has developed its proprietary transgenic mice (HuTCR mice) carrying the entire human TCRαβ gene loci. The T-cells of these HuTCR mice express a diverse human TCR repertoire. The company has also developed MAGE-A1 for the indication of myeloma.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 8k LinkedIn followers — 4.1% of this cohort's audience
Activity: 1 product launches · 1 expansions announced in 12 mo
Funding rounds
- Aug 2021Series B$110M
- Aug 2020Series A$78.2M
Founders & team
Investors
Fidelity Investments, Life Sciences Partners, Qatar Investment Authority, Casdin Capital, Sixty Degree Capital, RA Capital Management
Tech stack
Apache Http ServerBamboohrCloudflareCloudflare Bot ManagementDocusignGoogle Analytics
#10
Series A · Berlin, Berlin · founded 2021 · 26 employees$51.6Mraised▾
Series A · Berlin, Berlin · founded 2021 · 26 employees
Developer of drugs for systemic targeted radiation therapy to treat cancer. The lead radiopharmaceutical product, satoreotide is an antagonist of the somatostatin type 2 (SST2) receptor. It is used for the treatment of neuroendocrine cancers, small cell lung cancer, and neuroblastoma
LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers — 2.9% of this cohort's audience
Activity: 2 partnerships (incl. Nusano) announced in 12 mo
Funding rounds
- Apr 2023Series A$24.9M
- Jun 2022Series A$26.7M
Founders & team
Investors
Healthcap, EQT, Pureos Bioventures, Andera Partners, Earlybird, Ipsen
#11
Public · Berlin, Berlin · founded 1997 · 13 employees$93.3Mraised▾
Public · Berlin, Berlin · founded 1997 · 13 employees
Developer of aptamers to target the tumour microenvironment. The company has developed Spiegelmers, a variant of aptamers to target the tumour microenvironment for the treatment of cancer. Its lead candidate, NOX-A12, is under development as a combination therapy for several cancer indications such as Multiple Myeloma, Solid tumours, and Glioblastoma. Its platform technology has generated clinically validated assets that represent partnering opportunities. These include NOX-H94 under development for the treatment of anaemia of chronic disease and NOX-E36 for diabetic nephropathy.
Funding rounds
- Jan 2022Post IPO$19.3M
- Jun 2021Post IPO$2.8M
- Apr 2021Post IPO$1.5M
- Jun 2020Post IPO$1.5M
Investors
Atlas Capital Markets, Bmbf, Kreos Capital, NGN Capital, TVM Capital, Edmond de Rothschild
#12
Late Stage · Berlin, Berlin · founded 1992$16.4Mraised▾
Late Stage · Berlin, Berlin · founded 1992
Provider of radiation therapy products for cancer treatment and care. The company specializes in researching, developing, and manufacturing medical devices for radiation therapy. Its product portfolio includes linear accelerators, brachytherapy, intraoperative radiation therapy, and X-ray therapy devices. The company distributes its products worldwide.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers
Funding rounds
- Jan 2024PE$16.4M
- Jan 2020Grant (prize money)$78.8K
Founders & team
Investors
Cathay Capital, Europa
Tech stack
Animate.CssJqueryMicrosoft 365ModernizrNginxOpen Graph
Funding & investor landscape
$1.1Btotal disclosed funding
64companies funded
144disclosed rounds
2rounds last 90 days
Most active investors
IBB Ventures18 rounds
Notable founders
Alexander Thomas
Co-Founder · Cellbricks Therapeutics
Tobias Lam
Co-Founder & CTO · Cellbricks Therapeutics
Firas Khader
CTO & Co-founder · StratifAI
Daniel Truhn
Co-Founder & Chief Medical Officer · StratifAI
Maximilian Alber
Co-Founder & CTO · Aignostics
Klauschen Frederick
Co-Founder & Chief Medical Advisor · Aignostics
Werner Mäntele
Co-Founder & Head Of Research And Development · DiaMonTech
Werner Mantele
Co-Founder · DiaMonTech
Robin Rohm
Co-Founder & CEO & MD · Apheris
Michael Hoh
Co-Founder & CTO & MD · Apheris
Reimar Schlingensiepen
CEO · Audiocure
Fabian Queisner
Co-Founder & CEO · Nuuron
Prism market signals · Germany · country-scoped Prism corpus, 141,341 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH IN BERLIN · Health & Bio
How research on Biotechnology in Berlin is moving
A read on the academic research around Biotechnology in Berlin — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 91 papers.
Charité and Berlin Institute of Health lead Berlin's cautiously optimistic biotechnology research, focusing predominantly on immunology and epigenetics, with CAR-T and antibody therapies driving recent advancement.
91 papers · stance +0.38 · 34% breakthrough · 26% concern
top institutions
- Freie Universität Berlin31
- Charité - Universitätsmedizin Berlin31
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin17
- Humboldt-Universität zu Berlin15
- Technische Universität Berlin12
leading researchers
Alexander Kovacsovics · Anja Hess · Fabian Bachinger · Helene Kretzmer · Ludovic Vallier · Elmehdi Belbaraka
prism intelligence · tone & topics
87% positive · 4% critical tone
Medical ResearchPharmaceuticalsHealthAgricultureClinical TrialsGenetics
▲
Breakthroughs26 · 29%
▼ 33%→28% share
▼0.8× share momentum0 median citations85% since 2021mostly empirical
Gene, Immune system, and T cell research newly emerged and rising — all hitting 3 papers in Berlin biotech breakthroughs.
rising sub-themes (early→recent)
- Gene3
- Immune system3
- T cell3
- Cytotoxic T cell3
- Immunogenicity2
Newly emergingGene 0→3 · Immune system 0→3 · T cell 0→3
Landmark ProTox-II: a webserver for the prediction of toxicity of chemicals · 2,924 cites
◆
Advancements30 · 33%
▲ 0%→34% share
0 median citations90% since 2021mostly empirical
Advancements surged from 0% to 34% field-share, led by newly emerging Downregulation/upregulation and Microglia topics.
rising sub-themes (early→recent)
- Microglia3
- Downregulation and upregulation3
- DNA methylation2
- Gene2
- Inflammation2
Newly emergingDownregulation and upregulation 0→3
Landmark The Health Benefits of Dietary Fibre · 826 cites
▼
Concerns20 · 22%
▲ 17%→23% share
▲1.4× share momentum0 median citations90% since 2021mostly reviews
Antibiotic resistance and Production economics both newly emerged at 3 papers each, intensifying Berlin biotech concern signals.
rising sub-themes (early→recent)
- Antibiotic resistance3
- Production (economics)3
- Antimicrobial2
- Food processing2
- Product (mathematics)2
Newly emergingAntibiotic resistance 0→3 · Production (economics) 0→3
Landmark Pericytes in capillaries are contractile in vivo, but arterioles mediate functional hyperemia in the mouse brain · 393 cites
Common questions
How many Life Sciences companies are there in Berlin, Germany?
Radar tracks 238 indexable Life Sciences companies headquartered in Berlin, Germany that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Berlin, Germany?
The Life Sciences companies in Berlin, Germany on this list have raised a combined $1.1B in disclosed equity funding across 64 funded companies.
Which is the highest-funded Life Sciences company in Berlin, Germany?
T-Knife is the highest-funded Life Sciences company in Berlin, Germany, with $188.2M in disclosed equity funding.
How many Life Sciences companies in Berlin, Germany are funded?
64 of the 238 Life Sciences companies in Berlin, Germany on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Berlin, Germany?
None of the Life Sciences companies in Berlin, Germany on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Berlin, Germany Life Sciences companies?
The most active investors in Berlin, Germany Life Sciences companies on this list include Europa, IBB Ventures, HTGF, Freie Universitat Berlin, Entrepreneur First.
Rohit KhannaTrends & Stories
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.